Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 250 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2422 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

25 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2019-10-03 2019-10-10 95370
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
PORTIA 28 0.03MG 0.15MG TABLET Resolved 2019-09-26 2019-10-10 94874
PORTIA 21 0.03MG 0.15MG TABLET Resolved 2019-09-26 2019-10-10 94870
TEVA-LEVOCARBIDOPA 25MG 100MG TABLET Resolved 2019-09-26 2019-10-10 94864
TEVA-LACOSAMIDE 150MG TABLET Resolved 2019-10-03 2019-10-10 95387
PEMETREXED DISODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-10-17 93140
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
ACT RIZATRIPTAN 10MG TABLET Resolved 2019-09-05 2019-10-17 93169
ACT LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Resolved 2019-08-22 2019-10-24 92229
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
APRI 28 0.15MG 0.03MG TABLET Resolved 2019-08-29 2019-10-24 92660
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92666
TEVA-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92669
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
RATIO-NYSTATIN 100000UNIT CREAM Resolved 2019-08-29 2019-10-26 92678
RATIO-NYSTATIN 100000UNIT CREAM Resolved 2019-08-29 2019-10-26 92681
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2019-10-17 2019-10-26 96730
AVIANE 28 20MCG 100MCG TABLET Resolved 2019-09-26 2019-11-01 94828

Showing 401 to 420 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64861
TEVA-ENALAPRIL 16MG TABLET Discontinued 2018-10-19 2018-10-19 64866
TEVA-ENALAPRIL 4MG TABLET Discontinued 2018-10-19 2018-10-19 64869
ACT DONEPEZIL ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-10-19 2018-10-19 64872
ACT DONEPEZIL ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-10-19 2018-10-19 64875
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2018-10-19 2018-10-19 64909
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
TEVA-CLONAZEPAM 0.5MG TABLET Discontinued 2018-10-19 2018-10-19 64923
TEVA-CLONAZEPAM 0.5MG TABLET Discontinued 2018-10-19 2018-10-19 64926
TEVA-CLONAZEPAM 2MG TABLET Discontinued 2018-10-19 2018-10-19 64929
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2018-10-19 2018-10-19 64970
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2018-10-19 2018-10-19 64975
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2018-10-19 2018-10-19 64983
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2018-10-19 2018-10-19 64993
TEVA-NORFLOXACIN 400MG TABLET Discontinued 2018-10-19 2018-10-19 65013
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2018-10-19 2018-10-19 65017
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65020
TEVA-TRIMEL DS 800MG 160MG TABLET Discontinued 2018-10-19 2018-10-19 65023

Showing 61 to 80 of 250